Cellectar Biosciences Inc.
CLRB | NASDAQ
$2.34
-$0.01 (-0.43%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.93M | -5.65M | -5.3M | -4.44M | -5.45M | -6.6M | -2.36M | -14.66M | -919.37K | -26.64M | -7.88M | -17.52M | -10.18M | -7.19M | -7.22M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Depreciation & Amortization | 35.52K | -110.02K | 49.46K | 52.28K | 55.56K | 56.3K | 68.57K | 68.57K | 66.02K | 88.49K | 69.96K | 41.21K | 38.65K | 42.56K | 38.16K | 32.96K | 33.9K | 43.42K | 39.29K | 36.79K | 38.71K | 35.13K |
Stock-Based Compensation | 428.31K | n/a | n/a | n/a | 565.39K | 562.74K | 1.49M | 1.53M | n/a | 454.36K | n/a | 497.88K | 419.76K | 408.21K | 361.45K | 367.76K | 419.95K | 303.81K | 377.85K | 421.16K | 200.62K | 124.56K |
Other Working Capital | -448.52K | 245.5K | 202.63K | 487.59K | 176.4K | -3.74M | -63.57K | 2.22M | -716.76K | -2.22M | 219.21K | 740.65K | 205.06K | 946.83K | -620.16K | 374.41K | 1.2M | 731.43K | 969.39K | -1.09M | -1.11M | 1.42M |
Other Non-Cash Items | 411.31K | 371.62K | 290.12K | 292.92K | -464.97K | 340K | -10.05M | 1.67M | -11.64M | 14.96M | -3.37M | 8.17M | 1.99M | -1.39M | 23.89K | 23.01K | 25.56K | 21.36K | 20.56K | 19.79K | 19.05K | 21.26K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 45.34K | 546.78K | 611.5K | -176.44K | 176.4K | -3.74M | -63.57K | 2.22M | -1.65M | -2.22M | 1.58M | 740.65K | 205.06K | 946.83K | -620.16K | 374.41K | 1.2M | 731.43K | 969.39K | -1.09M | -1.11M | 1.42M |
Operating Cash Flow | -6.01M | -4.85M | -4.34M | -4.28M | -5.12M | -9.38M | -10.91M | -9.17M | -14.14M | -13.36M | -9.6M | -8.07M | -7.53M | -7.18M | -7.41M | -7.01M | -5.76M | -5.04M | -4.51M | -6.43M | -6.88M | -4.75M |
Capital Expenditures | n/a | -3.38K | -5.88K | 1 | n/a | 4 | -61.29K | 3 | -21.28K | -21.63K | -266.76K | -597.28K | -1 | n/a | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K | -1 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -61.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -3.38K | -5.88K | n/a | n/a | n/a | -61.29K | n/a | -21.28K | -21.63K | -266.76K | -597.28K | n/a | n/a | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.56M | n/a | 43.85M | n/a | 22.5M | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a | 34.87K | 1.21M |
Financial Cash Flow | 31.66M | n/a | 4.99M | 5.79M | 2.25M | n/a | n/a | 17.56M | 1 | 43.85M | 441K | 22.5M | n/a | 3 | 9.61M | n/a | n/a | n/a | -1 | n/a | 34.87K | 1.21M |
Net Cash Flow | 25.65M | -4.85M | 641.74K | 1.51M | -2.86M | -9.38M | -10.97M | 8.39M | -14.16M | 30.47M | -9.42M | 13.83M | -7.53M | -7.18M | 2.08M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.85M | -3.54M |
Free Cash Flow | -6.01M | -4.85M | -4.35M | -4.28M | -5.12M | -9.38M | -10.97M | -9.17M | -14.16M | -13.38M | -9.86M | -8.67M | -7.53M | -7.18M | -7.53M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.88M | -4.75M |
Adj. Free Cash Flow | -6.44M | -4.85M | -4.35M | -4.28M | -5.68M | -9.95M | -12.46M | -10.7M | -14.16M | -13.84M | -9.86M | -9.16M | -7.95M | -7.59M | -7.89M | -7.39M | -6.25M | -5.37M | -5.02M | -6.85M | -7.08M | -4.88M |
Maintenance CapEx | n/a | -3.38K | -5.88K | -1 | n/a | -4 | -61.29K | -3 | -21.28K | -21.63K | -69.96K | -41.21K | -1 | n/a | -38.16K | -7.07K | -33.9K | -30.07K | -39.29K | -4.06K | -7.56K | -1 |
Growth CapEx | n/a | n/a | n/a | 2 | n/a | 8 | n/a | 6 | n/a | n/a | -196.8K | -556.07K | n/a | n/a | -79.7K | n/a | -37.08K | n/a | -90.45K | n/a | n/a | n/a |
Owner Earnings | -6.01M | -4.85M | -4.35M | -4.28M | -5.12M | -9.38M | -10.97M | -9.17M | -14.16M | -13.38M | -9.67M | -8.11M | -7.53M | -7.18M | -7.45M | -7.02M | -5.79M | -5.07M | -4.55M | -6.43M | -6.88M | -4.75M |
Add to Watchlist
Select watchlists to add or remove CLRB